# Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)

> **NCT00927615** · NA · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 534 (actual)

## Conditions studied

- ST-Elevation Myocardial Infarction

## Interventions

- **DRUG:** abciximab
- **DRUG:** abciximab

## Key facts

- **NCT ID:** NCT00927615
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-05
- **Final completion:** 2011-04
- **Target enrollment:** 534 (ACTUAL)
- **Last updated:** 2010-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927615, "Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00927615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*